XPNPEP1 抗体 (AA 1-623)
Quick Overview for XPNPEP1 抗体 (AA 1-623) (ABIN204943)
抗原
See all XPNPEP1 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 1-623
- 
                                            特异性
- Recognizes human Aminopeptidase P1.
- 
                                            纯化方法
- Protein G purified
- 
                                            免疫原
- E. coli-derived recombinant human APP1 (aa1-623) Accession # NP_065116.
- 
                                            亚型
- IgG1
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- 
                        Approved: ELISA (0.5 - 1 μg/mL), WB (1 - 2 μg/mL)
 Usage: Suitable for use in Western Blot and ELISA. Western Blot: 1-2 μg/mL. ELISA: 0.5-1 μg/mL.
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Lyophilized
- 
                                            溶解方式
- deionized water
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- Lyophilized.
 
- 
                                            
- 
    - XPNPEP1 (X-Prolyl Aminopeptidase (Aminopeptidase P) 1, Soluble (XPNPEP1))
- 
                                            别名
- XPNPEP1 / Aminopeptidase P
- 
                                            背景
- 
                        Name/Gene ID: XPNPEP1
 Family: Exopeptidase
 Synonyms: XPNPEP1, Aminopeptidase P, cytosolic, APP1, SAMP, Xaa-Pro aminopeptidase 1, XPNPEPL, X-Pro aminopeptidase 1, XPNPEP, XPNPEPL1, Cytosolic aminopeptidase P, Soluble aminopeptidase P
- 
                                            基因ID
- 7511
- 
                                            NCBI登录号
- NP_065116
- 
                                            UniProt
- Q9NQW7
 抗原
- 
                    
 
                                     
                                     
                                    